FDA Approves Warning Label Changes for Testosterone and Other Anabolic Androgenic Steroids
October 26th 2016The FDA has approved class-wide labeling changes for prescription testosterone products regarding risks of abuse and dependence associated with testosterone and other anabolic androgenic steroids (AASs).
Read More
FDA Approves FluBlok Quadrivalent Flu Vaccine
October 13th 2016The FDA has approved its quadrivalent formulation of Protein Sciences' Flublok influenza vaccine for protection against 4 strains of influenza-3 of the same strains found in its trivalent version, along with an additional B strain. It is the first high-antigen-content quadrivalent flu vaccine approved by the FDA.
Read More